[Ip-health] Declaration of Members of the European Parliament calling for support on the UNITAID HIV Patent Pool

[Alexandra HEUMBER]

This is a multipart message in MIME format.
--
[ Picked text/plain from multipart/alternative ]
WRITTEN DECLARATION=0D
pursuant to Rule 123 of the Rules of Procedure=0D
on the UNITAID HIV patent pool=0D
Michael Cashman, David Martin, Ra=C3=BCl Romeva i Rueda, Santiago Fisas Ayx=
ela,=0D
Sophie In't Veld=0D
Lapse date: 11.2.2010=0D
=0D
0055/2009=0D
Written declaration on the UNITAID HIV patent pool=0D
The European Parliament,=0D
=E2=80=93       having regard to Rule 123 of its Rules of Procedure,=0D
A.      whereas only one third of the 10 million people in need of=0D
antiretroviral treatment has access to it and the price of medicines is on=
=0D
the rise, with increasing numbers of AIDS patients failing on their=0D
first-line therapy, and there is an urgent need to find affordable=0D
second-line treatments,=0D
=0D
B.      whereas two million children are living with HIV but less than 10=
=0D
% of them have access to the medicines they need, and many of the=0D
antiretroviral (ARV) drugs available are not approved for paediatric use,=
=0D
=0D
C.      whereas UNITAID has decided to take steps to create a voluntary=0D
patent pool for AIDS medicines for developing countries,=0D
=0D
D.      whereas, a patent pool is a mechanism whereby patents held by=0D
different parties are brought together voluntarily, in exchange for=0D
royalties, and made available for production and further development,=0D
=0D
1.      Calls on the Commission, the Council and the Member States of the=
=0D
EU to recognise the need for the UNITAID patent pool to ensure=0D
availability and affordability of HIV medicines for developing countries=0D
and to actively support the UNITAID HIV patent pool;=0D
=0D
2.      Calls, together with international humanitarian organizations, on=
=0D
the pharmaceutical companies to help accelerate the availability of new=0D
treatments for millions of people living with HIV/AIDS, by pooling their=0D
patents on a list of key HIV medicines;=0D
=0D
3.      Instructs its President to forward this declaration, together with=
=0D
the names of the=0D
        Signatories, to the Commission, the Council and the Member States.=
=0D
=0D
=0D
=0D
=0D
************************************************************=0D
Make It Happen ? Tell drug company bosses to share their patents and get=0D
drugs for people living with HIV=0D
https://www.actionformsfaccess.org/=0D
***********************************************************=0D
=0D
Alexandra Heumber=0D
EU & IP Policy Adviser=0D
=0D
M=C3=A9decins Sans Fronti=C3=A8res=0D
Access to Essential Medicines Campaign=0D
=0D
Rue Dupr=C3=A9, 94. 1090 Brussels=0D
++32 (0) 2 474 75 09 (Dir off)=0D
++ 32 (0) 479 514 900 (Mob)=0D
++ 32 (0) 2 474 75 75 (Fax)=0D
=0D
www.msfaccess.org=0D
Follow us on Twitter http://twitter.com/MSF_access=0D
=0D